Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ERIC 2018 | CLL cell dynamics

Nicholas Chiorazzi • 25 Oct 2018
ERIC 2018
Chronic Lymphocytic Leukemia Leukemia

Nicholas Chiorazzi, MD, of the Feinstein Institute of Medical Research, Manhasset, NY, discusses the dynamics of chronic lymphocytic leukemia (CLL) cells with us at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.

More from Nicholas Chiorazzi

Identifying new CLL therapeutic targets by focusing on the evolution of cancer cells 1:00
Identifying new CLL therapeutic targets by focusing on the evolution of cancer cells
Nicholas Chiorazzi • 7 Oct 2022
Leukemic cell birth rate & the role of recently divided B cells in CLL 2:49
Leukemic cell birth rate & the role of recently divided B cells in CLL
Nicholas Chiorazzi • 7 Oct 2022
Obstacles to achieving a cure in CLL 1:02
Obstacles to achieving a cure in CLL
Nicholas Chiorazzi • 7 Oct 2022
Updates on cellular and molecular interactions in the CLL microenvironment 3:56
Updates on cellular and molecular interactions in the CLL microenvironment
Nicholas Chiorazzi • 18 Sep 2021

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals